<DOC>
	<DOCNO>NCT01133405</DOCNO>
	<brief_summary>This Phase 1 study healthy subject evaluate safety tolerability LY2886721 single dos , body handle drug , drug 's effect body .</brief_summary>
	<brief_title>A Safety Study LY2886721 Single Doses Healthy Subjects</brief_title>
	<detailed_description>This Phase 1 study 2 part , healthy subject . Part 1 subject- investigator-blind , placebo-controlled , randomize , 3-period , crossover study . Part 1 assess safety tolerability LY2886721 single dos , body handle drug , drug 's effect body . Part 2 subject- investigator-blind , placebo-controlled , randomize study ass safety tolerability LY2886721 single dose , body handle drug , drug 's effect body include cerebrospinal fluid .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy men nonchildbearing potential woman 20 year old Body mass index 1832 kg/m2 Taking overthecounter prescription medication exception vitamins mineral stable dos thyroid estrogen hormone replacement Smoke 10 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>